Although adiponectin is generally referred to an anti-inflammatory and neuroprotective molecule, several clinical studies have described the so-called “adiponectin paradox”, whereby higher circulating adiponectin levels are paradoxically associated with cognitive decline, Alzheimer’s disease and frailty in older adults. The gene discussed is ADIPOQ; the disease is early-onset autosomal dominant Alzheimer disease.